FDA authorizes second antiviral pill to treat Covid-19

FDA authorizes second antiviral pill to treat Covid-19 (cnn.com)

FDA authorizes second antiviral pill to treat Covid-19

The US Food and Drug Administration on Thursday authorized Merck's antiviral pill, molnupiravir, to treat Covid-19 "for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death, and for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or clinically appropriate."

This is the second Covid-19 antiviral pill authorized for ill people to take at home, before they get sick enough to be hospitalized. Merck has an agreement with the US government for the company to supply 3.1 million courses of molnupiravir upon this authorization.
 
Submitted by mo2 on Wed, 12/22/2021 - 22:25